Tumor necrosis factor-α induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface
Open Access
- 15 August 2001
- journal article
- Published by American Society of Hematology in Blood
- Vol. 98 (4) , 1108-1115
- https://doi.org/10.1182/blood.v98.4.1108
Abstract
It is demonstrated that similar to interferon γ (IFN-γ), tumor necrosis factor-α (TNF-α) induces coordinated changes at different steps of the major histocompatibility complex (MHC) class I processing and presentation pathway in nonprofessional antigen-presenting cells (APCs). TNF-α up-regulates the expression of 3 catalytic immunoproteasome subunits—LMP2, LMP7, and MECL-1—the immunomodulatory proteasome activator PA28α, the TAP1/TAP2 heterodimer, and the total pool of MHC class I heavy chain. It was also found that in TNF-α–treated cells, MHC class I molecules reconstitute more rapidly and have an increased average half-life at the cell surface. Biochemical changes induced by TNF-α in the MHC class I pathway were translated into increased sensitivity of TNF-α–treated targets to lysis by CD8+ cytotoxic T cells, demonstrating improved presentation of at least certain endogenously processed MHC class I–restricted peptide epitopes. Significantly, it was demonstrated that the effects of TNF-α observed in this experimental system were not mediated through the induction of IFN-γ. It appears to be likely that TNF-α–mediated effects on MHC class I processing and presentation do not involve any intermediate messengers. Collectively, these data demonstrate the existence of yet another biologic activity exerted by TNF-α, namely its capacity to act as a coordinated multi-step modulator of the MHC class I pathway of antigen processing and presentation. These results suggest that TNF-α may be useful when a concerted up-regulation of the MHC class I presentation machinery is required but cannot be achieved by IFN-γ.Keywords
This publication has 63 references indexed in Scilit:
- TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMSAnnual Review of Immunology, 1999
- DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDESAnnual Review of Immunology, 1999
- Thimet Oligopeptidase (EC 3.4.24.15), a Novel Protein on the Route of MHC Class I Antigen PresentationBiochemical and Biophysical Research Communications, 1999
- Clinical applications of TNF-α in cancerCurrent Opinion in Immunology, 1998
- The α Chain of the T Cell Antigen Receptor Is Degraded in the CytosolImmunity, 1997
- Point mutations in the α2 domain of HLA-A2.1 define a functionally relevant interaction with TAPCurrent Biology, 1996
- Human transporters associated with antigen processing possess a promiscuous peptide-binding siteImmunity, 1994
- The Molecular Basis of AllorecognitionAnnual Review of Immunology, 1993
- Brefeldin A: insights into the control of membrane traffic and organelle structure.The Journal of cell biology, 1992
- Peptide binding to empty HLA-B27 molecules of viable human cellsNature, 1991